Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10526413 Bispecific antibodies specific for OX40

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
September 29, 2016
0
Date of Patent
January 7, 2020
0
Patent Application Number
15280379
0
Patent Citations
‌
US Patent 10040843 Interleukin-10 fusion proteins and uses thereof
Patent Citations Received
‌
US Patent 11447558 Bispecific antigen binding molecules comprising anti-4-1BB clone 20H4.9
‌
US Patent 11242396 Bispecific antigen binding molecules comprising anti-FAP clone 212
‌
US Patent 11608376 Tumor-targeted agonistic CD28 antigen binding molecules
0
‌
US Patent 11639394 Bispecific antigen binding molecule for a costimulatory TNF receptor
0
‌
US Patent 11267903 Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer
0
‌
US Patent 11292848 Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof
‌
US Patent 11306154 Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer
‌
US Patent 11999789 Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof
0
‌
US Patent 12065478 HER2-targeting antigen binding molecules comprising 4-1BBL
0
‌
US Patent 11999800 Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer
0
•••
Patent Inventor Names
Christian Klein
0
Christina Claus
0
Claudia Ferrara Koller
0
Maria Amann
0
Pablo Umana
0
Peter Bruenker
0
Ralf Hosse
0
Sandra Grau-Richards
0
Viktor Levitski
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10526413
0
Patent Primary Examiner
‌
Robert S. Landsman
0

Find more entities like US Patent 10526413 Bispecific antibodies specific for OX40

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo